Metastatic extramammary Paget’s disease successfully treated by trastuzumab deruxtecan: a rare case report - Top-Institutions - MDSpire

Metastatic extramammary Paget’s disease successfully treated by trastuzumab deruxtecan: a rare case report

  • By

  • Lien-Ping Chou

  • Ming-Yang Lee

  • Chien-Liang Fang

  • Chun-Liang Tung

  • I-Li Lin

  • Cheng-Huang Shen

  • June 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #3

    University of California, Los Angeles
    University of California, Los Angeles

    Los Angeles, CA

    Key Differentiators

    • Oncology

  • #4

    University of Pittsburgh
    University of Pittsburgh

    Pittsburgh, PA

    Key Differentiators

    • Oncology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Oncology

Original Source(s)

Metastatic extramammary Paget’s disease successfully treated by trastuzumab deruxtecan: a rare case report

  • by Lien-Ping Chou, Ming-Yang Lee, Chien-Liang Fang, Chun-Liang Tung, I-Li Lin, Cheng-Huang Shen

  • June 24, 2026

Related Content

Largest single-institution series of robotic pneumonectomy

The NLRP3 inflammasome in gynecological cancers: a double-edged sword shaping the immune microenvironment and immunotherapy response

Advancing glioblastoma research by establishing a whole brain slice model